NCI-H929（人骨髓瘤細(xì)胞）
CBP60243
詢 價(jià)
索取STR
產(chǎn)品描述
產(chǎn)品數(shù)據(jù)庫(kù)
| I. General information | |
| Synonyms: | NCI-H929 |
| Background: | This cell line was established from a malignant effusion in a patient with myeloma. |
| Species: | Homo sapiens, human |
| Tissue: | bone marrow |
| Disease: | plasmacytoma; myeloma |
| Gender: | female, 62 years, Caucasian |
| Morphology: | lymphoblast |
| Growth Mode: | suspension |
| DNA Profile: | Amelogenin: X CSF1PO: 11 D13S317: 12 D16S539: 9,13 D5S818: 11,12 D7S820: 10,12 THO1: 9.3 TPOX: 8,11 vWA: 14,15 Our Cell Line Authentication Service |
| Culture Medium: |
RPMI-1640+10%FBS NCI-H929完全培養(yǎng)基，# CBP60243M |
| Cryopreservation medium: | 90%FBS+10%DMSO |
| Antigen Expression: | PCA-1; CD38 + |
| Receptor Expression: | transferrin |
| Genes Expressed: | PCA-1; CD38 + |
| Comments: | The cells are positive for plasma cell antigen 1 (PCA-1), transferrin receptor, CD38 (T10), but are negative for HLA DR, CALLA and markers of early B cell development. They are negative for Epstein-Barr virus nuclear antigen (EBNA). The cells have a rearrangement of the c-myc proto oncogene and express c-myc RNA. There is also an activated ras allele. For more information, please contact us (4008-750-250). |
